BlackRock Investment Management’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

BlackRock Investment Management’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2K	Hold	120	–	–	﹤0.01%	3893
2016 Q3	$14K	Hold	120	–	–	﹤0.01%	3476
2016 Q2	$9K	Buy	120 +8	+7%	+$693	﹤0.01%	3680
2016 Q1	$8K	Hold	112	–	–	﹤0.01%	3707
2015 Q4	$10K	Hold	112	–	–	﹤0.01%	3694
2015 Q3	$13K	Buy	112 +27	+32%	+$3.11K	﹤0.01%	3587
2015 Q2	$9K	Buy	85 +17	+25%	+$1.76K	﹤0.01%	3780
2015 Q1	$7K	Hold	68	–	–	﹤0.01%	3782
2014 Q4	$6K	Hold	68	–	–	﹤0.01%	3861
2014 Q3	$5K	Hold	68	–	–	﹤0.01%	3904
2014 Q2	$5K	Buy	+68	New	+$5.29K	﹤0.01%	3883

Other funds holding PLXP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Middleton & Co Boston, Massachusetts $877M AUM 15.2% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BlackRock Investment Management's PLXP Position: Q4 2016 in Review

BlackRock Investment Management held its PLx Pharma Inc. Common Stock (PLXP) position steady in Q4 2016 at 120 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #3893.

BlackRock Investment Management first reported a position in PLXP in Q2 2014 and has held it in 11 quarters since. The position peaked at $14K in Q3 2016. 19 funds tracked by Wall St. Rank hold PLXP as of Q4 2016.

BlackRock Investment Management held 120 shares of PLx Pharma Inc. Common Stock worth $2K as of Q4 2016.
BlackRock Investment Management left its PLx Pharma Inc. Common Stock share count unchanged in Q4 2016.
PLx Pharma Inc. Common Stock made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3893 holding.
BlackRock Investment Management first reported a position in PLx Pharma Inc. Common Stock in Q2 2014 and has held it in 11 quarters since.
BlackRock Investment Management's PLx Pharma Inc. Common Stock position peaked at $14K in Q3 2016.
19 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.